ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Avecho Biotechnology Limited

Avecho Biotechnology Limited (AVE)

0.003
0.00
(0.00%)
Closed February 01 12:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.003
Bid
0.003
Ask
0.004
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.005
Market Cap
Previous Close
0.003
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,172,084
Shares Outstanding
3,169,297,013
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0
Revenue
1.59M
Net Profit
-3.44M

About Avecho Biotechnology Limited

Sector
Pharmaceutical Preparations
Industry
Financial Services Div'd
Headquarters
Melbourne, Victoria, Aus
Founded
1992
Avecho Biotechnology Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker AVE. The last closing price for Avecho Biotechnology was AUD0. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.001 to AUD 0.005.

Avecho Biotechnology currently has 3,169,297,013 shares outstanding. The market capitalization of Avecho Biotechnology is AUD9.51 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of 0.00.

AVE Latest News

Aventis Named to List of Top 100 Companies for Working Mothers

Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis announced today that it received a second rejection from...

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of Six Randomized Trials Published in JAMA...

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that...

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement

Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine for Clinical Trials SWIFTWATER, Pa., May 27...

Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004

Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that pending the...

Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients

Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients Findings Presented Suggest Minimal Potential for Adverse Effects Commonly Seen With Inhaled...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.001-250.0040.0040.0032823030.0030822DE
4000.0030.0040.00212149960.00285603DE
120.001500.0020.0040.00231720840.00323092DE
26000.0030.0040.00130729970.00264066DE
52000.0030.0050.00134495050.00331707DE
156-0.011-78.57142857140.0140.0230.00122754020.00556863DE
260-0.001-250.0040.0450.00129915930.01475027DE

AVE - Frequently Asked Questions (FAQ)

What is the current Avecho Biotechnology share price?
The current share price of Avecho Biotechnology is AUD 0.003
How many Avecho Biotechnology shares are in issue?
Avecho Biotechnology has 3,169,297,013 shares in issue
What is the market cap of Avecho Biotechnology?
The market capitalisation of Avecho Biotechnology is AUD 9.51M
What is the 1 year trading range for Avecho Biotechnology share price?
Avecho Biotechnology has traded in the range of AUD 0.001 to AUD 0.005 during the past year
What is the cash to sales ratio of Avecho Biotechnology?
The cash to sales ratio of Avecho Biotechnology is 0
What is the reporting currency for Avecho Biotechnology?
Avecho Biotechnology reports financial results in AUD
What is the latest annual turnover for Avecho Biotechnology?
The latest annual turnover of Avecho Biotechnology is AUD 1.59M
What is the latest annual profit for Avecho Biotechnology?
The latest annual profit of Avecho Biotechnology is AUD -3.44M
What is the registered address of Avecho Biotechnology?
The registered address for Avecho Biotechnology is UNIT A8, 2A WESTALL ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
What is the Avecho Biotechnology website address?
The website address for Avecho Biotechnology is www.avecho.com.au
Which industry sector does Avecho Biotechnology operate in?
Avecho Biotechnology operates in the FINANCIAL SERVICES DIV'D sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CR3ODCore Energy Minerals Ltd
AUD 0.003
(200.00%)
3.57M
NAGONagambie Resources Limited
AUD 0.002
(100.00%)
550k
NRZONeuRizer Ltd
AUD 0.003
(50.00%)
6.13k
EELENRG Elements Ltd
AUD 0.0015
(50.00%)
21.49k
MVPMedical Developments International Limited
AUD 0.645
(48.28%)
1.42M
ATHOAlterity Therapeutics Limited
AUD 0.007
(-41.67%)
46.52M
ATHAlterity Therapeutics Ltd
AUD 0.0115
(-36.11%)
123.58M
BDTBirdDog Technology Ltd
AUD 0.037
(-33.93%)
7.86M
NRZNeuRizer Ltd
AUD 0.002
(-33.33%)
5.92M
MGUOMagnum Mining and Exploration Ltd
AUD 0.002
(-33.33%)
1.14M
ATHAlterity Therapeutics Ltd
AUD 0.0115
(-36.11%)
123.58M
VAUVault Minerals Ltd
AUD 0.385
(5.48%)
49.45M
ATHOAlterity Therapeutics Limited
AUD 0.007
(-41.67%)
46.52M
SYASayona Mining Limited
AUD 0.023
(4.55%)
42.72M
LOTLotus Resources Limited
AUD 0.25
(6.38%)
42.53M

Discussion

View Full Feed
pgsd pgsd 11 minutes ago
Experts Forecast Cancer Research and Treatment Advances in 2025 :
January 10, 2025

Advances in Immunotherapy in 2025 :

"He said that there has already been early proof of concept that vaccines may help the immune system fight cancers that typically harbor very fe
NWBO
doinit doinit 13 minutes ago
a new addition to sales potential,, In 2022, Mitsubishi reached an agreement with Alaska Gasline Development Corporation (AGDC), the state-owned company overseeing the LNG proposal, to assess the feasibility of producing ammonia there. Mitsubishi has not committed to the project beyond an assessment
PTHRF
max mastiff max mastiff 24 minutes ago
Morning Drug Doctor I was wondering if you are in the HMBL stock that’s supposed to be merging if you are what are your thoughts on it
HMBL
nowwhat2 nowwhat2 24 minutes ago
System Maint THIS Wknd ?........Yikes



https://investorshub.advfn.com/uimage/uploads/2025/2/1/cbbliBTC_@_1_15D_GLITCH_HELP_MAG_100K.jpg

Last 101,888





Jan 16
https://investorshub.advfn.com/uimage/uplo
doinit doinit 25 minutes ago
Japan pledge to finance LNG pipeline in AK... https://www.oilandgas360.com/exclusive-japan-weighs-alaska-lng-pipeline-pledge-to-win-trumps-favour/#utm_source=rss&utm_medium=rss&utm_campaign=exclusive-japan-weighs-alaska-lng-pipeline-pledge-to-win-trumps-favour
PTHRF
trader53 trader53 25 minutes ago
DPLS - "Short Squeeze" Explained


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636946062923800000

________________________________________________


DPLS
trader53 trader53 26 minutes ago
DPLS - "Short Squeeze" Explained


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636946062923800000

________________________________________________


DPLS
bbotcs bbotcs 27 minutes ago
lj: This type of journalism can start a panic in the market: https://www.dailymail.co.uk/news/article-14348965/Hedge-funds-massive-bet-stock-market-crash-raises-alarm.html
nowwhat2 nowwhat2 30 minutes ago
Oh-oh

https://investorshub.advfn.com/uimage/uploads/2025/2/1/cbbliBTC_@_1_15D_GLITCH_HELP_MAG_100K.jpg


Last 101,888





Spidey senses.......

Jumbo glitch
BTCUSD
pgsd pgsd 32 minutes ago
MSD (Merck) Ireland announces acquisition of WuXi Vaccines’ Dundalk site

MSD's acquisition of the WuXi Vaccines Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its footprint to eight locations nationwide with over 3,000 currently employed across th
NWBO
threewheeler threewheeler 42 minutes ago
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
threewheeler threewheeler 43 minutes ago
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
threewheeler threewheeler 43 minutes ago
KRTLBIOTECH OTC:KRTL
@KRTLBiotech
Attention $KRTL shareholders: Management is scheduling one of several press releases for the beginning of next week.
8:45 PM · Jan 31, 2025
·
341
Views
KRTL
Drugdoctor Drugdoctor 48 minutes ago
Well, once a company takes over a shell, and changes the name to their new company, previous owners will quickly be forgotten. It's up to the new company to do their own image building. I think there was more than the problem with the holligans at play here.
GVSI
Looking4aprofit Looking4aprofit 49 minutes ago
Further to the post, I asked Gemini about this ruling and Discovery :

Yes, this ruling will likely lead to discovery, at least regarding the claims that survived the motion to dismiss.

Here's why:

Motion to Dismiss Stage: The document you provided is rela
NWBO
dhyan40 dhyan40 50 minutes ago
The Silver Suppression and Systemic Risk
Silver continues to be a key industrial and monetary asset. The current gold-to-silver ratio stands at 88:1 - significantly above historical norms of 16:1 - prompting discussions around price alignment. With a four-year supply deficit and increasing in
LEHNQ
nowwhat2 nowwhat2 51 minutes ago
I so showed you this was coming....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175568712

https://investorshub.advfn.com/uimage/uploads/2025/2/1/ijevsplby_121212_17_w__cup__girl.jpg

That was on December 16th
Jan 31 NEWS https://www.mark
PLBY
Seminole Red Seminole Red 56 minutes ago
Amy Klobuchar Attempts To Set A Trap For Kash Patel. It Does Not Go Well.

Patel asked Committee Chair Sen. Chuck Grassley (R-IA) for extra time, after which Klobuchar interrupted and repeatedly demanded that Patel answer her question.

Instead, Patel was given a moment t
jimjet218 jimjet218 1 hour ago
Your two BIG issues are not "BIG" to some of us.

As you yourself said the interaction between the potential "partners" is about data. You are correct in that we don't and can't know when the data will be enough. Could be weeks could be months. I don't see it as a BIG issue. Data,
LWLG
4u2nv2 4u2nv2 1 hour ago
My credibility was in question because of what time of the day or night I post comments? Here is a comment for you - There are no paid bashers here and no one is in a short position on IFUS. Here is what I see, a bunch of insiders at IFUS or people connected to them that are pointing their middle fi
IFUS
JesterHaven311 JesterHaven311 1 hour ago
Quite a few at AGSM. All resolutions passed including share consolidation. Hopefully we get more interest from II. Murphy is hanging on 😁and sale of LLP also went through 👋👋👋 So 284,362 CRML shares in the bank on 28 feb. So if CRML price stays the same as yesterday ($
REZZF
Bsparks11 Bsparks11 1 hour ago
Best idea I’ve heard in years. You’re onto something here bee. Let’s get ninja to bankroll. 😉
GAHC
Bsparks11 Bsparks11 1 hour ago
Buy Ninja, buy!!! lol. 😂
GAHC
Bsparks11 Bsparks11 1 hour ago
Buy Ninja, buy!!! lol. 😂
GAHC
Seminole Red Seminole Red 1 hour ago
Gusts approaching 30 mph are in the forecast, along with spots of rain. Pebble Beach, that felicitous meeting of land and sea, is a beast in nasty weather.

Your Recent History

Delayed Upgrade Clock